Arvinas Banner Image


  • Ticker ARVN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arvinas Logo Image
  • 201-500 Employees
  • Based in New Haven, Connecticut
Arvinas is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designedMore to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
4.8 / 5.0 (161)

Arvinas reports have an aggregate usefulness score of 4.8 based on 161 reviews.


Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Arvinas Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!